Sarah Church, a clinical psychologist and executive director of Wholeview Wellness in New York City, said more robust studies are needed "It is critical for us to get the results of a randomized controlled trial that compares GLP-1s to the other FDA-approved medications for (alcohol addiction) before we jump to conclusions about the relative effectiveness of the different medications," Church said. Read More

Traditionally, most of the alcohol and substance use treatment centers in the United States have focused on abstinence-based approaches, many of which follow a 12-step model. Their guiding philosophy reflects a belief in the disease model of addiction. Read More

The recent news that Matthew Perry’s death was partially caused by his use of recreational ketamine has brought renewed attention to the controversy surrounding this drug. It was first approved by the FDA as an anesthetic in 1970 and later it moved into popular culture and became a club drug used at raves, nightclubs, and music festivals by revelers interested in its dissociative and hallucinogenic properties. Read More

As rates of opioid addiction and substance abuse continue to grow in the United States, the crisis is also beginning to negatively impact employers. A recent New York Times article highlighted startling increases in overdoses in workplaces throughout the country. Read More

Every day and every news cycle there are stories about people struggling with addiction and the stakes are only getting higher with over 70,000 people succumbing to overdose last year. August 31st was International Overdose Awareness Day, a day when we remember those we have lost to overdose and bring attention to this issue to try to prevent future overdoses. Read More